PROSTATE CANCER AND PROSTATIC DISEASES Journal
Overview
publication venue for
- Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS). 28:865-873. 2024
- Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2) 2024
- Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2) 2024
- Enzalutamide versus bicalutamide in patients with nonmetastatic castration-resistant prostate cancer: a prespecified subgroup analysis of the STRIVE trial (Oct, 10.1038/s41391-021-00465-7, 2021) 2021
- Enzalutamide versus bicalutamide in patients with nonmetastatic castration-resistant prostate cancer: a prespecified subgroup analysis of the STRIVE trial. 25:363-365. 2021
- Next-generation imaging in localized high-risk prostate cancer 2021
- Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting. 21:78-84. 2018
- Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting. 21:78-84. 2018
- Decipher correlation patterns post prostatectomy: initial experience from 2342 prospective patients. 19:374-379. 2016
- Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer 2016
- A review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacers 2015
Research
category
- ONCOLOGY Web of Science Category
- UROLOGY & NEPHROLOGY Web of Science Category
Identity
International Standard Serial Number (ISSN)
- 1365-7852
Electronic International Standard Serial Number (EISSN)
- 1476-5608
Other
journal abbreviation
- PROSTATE CANCER P D